EDIT · Forms 3, 4, 5
Insider trades at Editas Medicine, Inc.
3 insiders sold $34K of Editas Medicine, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Editas Medicine, Inc. (EDIT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Daniel Scott Ory | EVP, Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Daniel Scott Ory | EVP, Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Sell (10b5-1 plan) | 709 | $3.04 | $2K | Form 4 | |
| Amy Parison | SVP, Chief Financial Officer | Sell (10b5-1 plan) | 453 | $3.04 | $1K | Form 4 | |
| Gilmore Neil O'Neill | CEO | Sell (10b5-1 plan) | 5,124 | $3.04 | $16K | Form 4 | |
| Patrick Thomas Ellinor II | Director | Options or other derivatives | Form 4 | ||||
| Patrick Thomas Ellinor II | Director | Became an insider (Form 3) | Form 3 | ||||
| Amy Parison | SVP, Chief Financial Officer | Sell (10b5-1 plan) | 678 | $2.58 | $2K | Form 4 | |
| Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Sell (10b5-1 plan) | 4,928 | $2.67 | $13K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.